The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts
Publication date: Available online 25 March 2017 Source:Journal of Cancer Policy Author(s): C. Morgan, M. Cira, A. Karagu, F.C. Asirwa, N.R. Brand, N. Buchanan Lunsford, S.M. Dawsey, A. Galassi, A. Korir, L. Kupfer, P.J. Loehrer, D. Makumi, L. Muchiri, S. Sayed, H. Topazian, J. Welch, M.J. Williams, K. Duncan Background In response to a growing cancer burden and need for improved coordination among stakeholders in Kenya, the US National Cancer Institute and the Kenya Ministry of Health collaboratively hosted a stakeholder meeting in 2014 which identified four priority areas of need (research capacity bu...
Source: Journal of Cancer Policy - March 25, 2017 Category: Cancer & Oncology Source Type: research
Sociodemographic factors associated with stage of diagnosis and treatment uptake among patients with colorectal cancer: A brief report
Conclusions Sociodemographic disparities were present among women and younger patients related to disease stage at diagnosis. Future research is needed to corroborate the presence of and psychosocial mechanisms behind disparities in diagnosis and treatment uptake among patients with CRC. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 20, 2017 Category: Cancer & Oncology Source Type: research
Building a law and NCDs workforce: a necessity for global cancer and NCD prevention and control
Publication date: Available online 16 March 2017 Source:Journal of Cancer Policy Author(s): Jonathan Liberman absp (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 16, 2017 Category: Cancer & Oncology Source Type: research
Urban-rural differentials in the uptake of mammography and cervical cancer screening in Kenya
Conclusion Findings suggest that interventions to promote breast and cervical cancer screening utilization are necessary for rural women. Regional barriers that are preventing rural women from using the screening services as well as their urban counterparts needs to be identified. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 14, 2017 Category: Cancer & Oncology Source Type: research
The New Risk-Sharing Paradigm In Rare Cancers: Patient Perspective
Publication date: Available online 14 March 2017 Source:Journal of Cancer Policy Author(s): Ornella Gonzato Advances in understanding the biology of rare cancers and in genomic technologies are reshaping drug development and are fostering patients’ hopes because an increasing number of drugs are expected to be made available. However, timely patient access to innovative drugs in rare cancers continues to encounter methodological and regulatory hurdles in an environment more and more characterised by limited resources and health systems under pressure. Decisions on drug pricing and reimbursement often delay access to a...
Source: Journal of Cancer Policy - March 14, 2017 Category: Cancer & Oncology Source Type: research
The Use of Tobacco Tax Revenues to Fund the Guam Cancer Registry: A Double Win for Cancer Control
Publication date: Available online 12 March 2017 Source:Journal of Cancer Policy Author(s): Annette M. David, Robert L. Haddock, Renata Bordallo, Janet T. Dirige, Les Mery (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 12, 2017 Category: Cancer & Oncology Source Type: research
Skin Cancer in the Youth Population of the United Kingdom
Publication date: Available online 9 March 2017 Source:Journal of Cancer Policy Author(s): Fabienne Marie-Louise Robertson, Lisa Fitzgerald Skin cancer is disproportionately high in the youth population of the United Kingdom, as compared with other cancers, yet it is a topic which so far has received little recognition, subsequently relevant literature is relatively scarce. In the United Kingdom, malignant melanoma is now one of the commonest cancers in those aged 15-34 years. Furthermore, malignant melanoma the 7th most common cancer in men, and 5th most common cancer in women in the United Kingdom in 2013 accounting ...
Source: Journal of Cancer Policy - March 9, 2017 Category: Cancer & Oncology Source Type: research
A medico-economic study of trabectedin compared with end-stage treatment in soft tissue sarcomas
Publication date: Available online 9 March 2017 Source:Journal of Cancer Policy Author(s): Johanne Daupin, Pascal Paubel, Daniele G. Soares, Jean-Pierre Lotz The development of new anticancer drugs has strongly contributed to improve patients’ outcomes. However, the question can be raised whether the sometimes minor benefits are worth the cost to both the individuals and the society. The aim of this medico-economic study was to evaluate trabectedin cost-effectiveness compared with end-stage care in the treatment of soft-tissue sarcoma. We retrospectively analysed data from 45 patients treated with trabectedin for s...
Source: Journal of Cancer Policy - March 9, 2017 Category: Cancer & Oncology Source Type: research
Cost-effectiveness analysis of the use of comprehensive molecular profiling before initiating monoclonal antibody therapy against metastatic colorectal cancer in Japan
Conclusion The incremental cost per QALY gained indicated that comprehensive screening was more cost-effective compared to RAS screening. With a willingness-to-pay value of 6 million JPY/QALY, comprehensive screening can be considered for the genetic testing of patients before providing monoclonal antibody therapy. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 9, 2017 Category: Cancer & Oncology Source Type: research
The availability of essential cancer medication: An analysis of national formularies
Conclusion With national formularies analyzed for over 80% of all LMICs, this study found that most LMICs listed under half of cancer medications considered by the WHO to be essential. LMIC decision-making for policies related to cancer drug access may be heavily influenced by economic development, as well as by the high prevalence of certain cancer risk factors. The results from this study suggest that LMICs are generally ill-prepared to adequately provide essential treatment for their rapidly rising numbers of cancer patients. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 9, 2017 Category: Cancer & Oncology Source Type: research
Supporting Evidence-Based National Cancer Control Planning: The Asia-Pacific Phase II Leadership Forum
Publication date: Available online 9 March 2017 Source:Journal of Cancer Policy Author(s): Tulika Singh, Paul C. Pearlman, Brenda Kostelecky (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - March 9, 2017 Category: Cancer & Oncology Source Type: research
The health and economic implications of the use of tanning devices
Conclusions The use of tanning devices is a significant contributor to illness and premature mortality in the U.S., and also represents a major economic burden in terms of the costs of medical care and lost productivity. (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - February 28, 2017 Category: Cancer & Oncology Source Type: research
Cancer Patent Scenario in Brazil: Analysis of Competitive Advantages
Publication date: Available online 23 December 2016 Source:Journal of Cancer Policy Author(s): William de Oliveira Avellar, João M.Brambati Sant, Daniele Ferreira, Flavia V.G. Alves, Veronica Aran, Carlos Gil Ferreira The present study describes the geographical and sectorial profile of chemical and biotechnological patents, regarding prevention, diagnosis, and treatment for the most frequent cancer types in Brazil that are currently registered in the Brazilian National Institute of Industrial Property − INPI, from 1998 until 2013. The steps taken to generate competitive advantage in the Brazilian oncological dr...
Source: Journal of Cancer Policy - December 22, 2016 Category: Cancer & Oncology Source Type: research
Defining Care Trajectories: The Example of Endometrial Cancer
Publication date: Available online 16 December 2016 Source:Journal of Cancer Policy Author(s): François Béland, Claude Galand, John D. Fletcher, Walter H. Gotlieb, Jeremie Abitbol, Dominic Julien Background The era of patient-centered care might lead to the conclusion that there are as many configurations of healthcare utilization within episodes of care as there are patients. However, variability among episodes of care is limited by factors such as local resources or patient characteristics. As a result, the differences among episodes of care are reduced, and a limited number of care trajectories are expected. ...
Source: Journal of Cancer Policy - December 16, 2016 Category: Cancer & Oncology Source Type: research
High-cost cancer imaging: Opportunities for utilization management
Publication date: Available online 14 December 2016 Source:Journal of Cancer Policy Author(s): Timothy P. Copeland, Benjamin L. Franc (Source: Journal of Cancer Policy)
Source: Journal of Cancer Policy - December 14, 2016 Category: Cancer & Oncology Source Type: research
